2016

  1. Adalimumab +/- azathioprine in CD

  2. Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

  3. Ustekinumab in CD safety

  4. Treatment of CD with an IgG4-Guided Exclusion Diet

  5. Allogeneic adipose-derived mesenchymal stem cells (Cx601) in perianal CD

  6. Granulocyte/Monocyte Apheresis in UC

  7. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with CD